Metropolis Healthcare Resultados de beneficios anteriores
Pasado controles de criterios 2/6
Metropolis Healthcare ha aumentado sus beneficios a una tasa media anual de 3.6%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 29.7% anual. Los ingresos han ido creciendo a una tasa media de 9.9% al año. La rentabilidad financiera de Metropolis Healthcare es de 12%, y sus márgenes netos son de 10.8%.
Información clave
3.6%
Tasa de crecimiento de los beneficios
3.1%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare | 29.4% |
Tasa de crecimiento de los ingresos | 9.9% |
Rentabilidad financiera | 12.0% |
Margen neto | 10.8% |
Última actualización de beneficios | 31 Dec 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Metropolis Healthcare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 11,593 | 1,248 | 3,889 | 77 |
30 Sep 23 | 11,536 | 1,334 | 3,840 | 75 |
30 Jun 23 | 11,454 | 1,383 | 3,758 | 63 |
31 Mar 23 | 11,482 | 1,429 | 3,730 | 66 |
31 Dec 22 | 11,716 | 1,495 | 3,806 | 77 |
30 Sep 22 | 11,792 | 1,548 | 3,785 | 78 |
30 Jun 22 | 11,814 | 1,727 | 3,688 | 76 |
31 Mar 22 | 12,283 | 2,142 | 3,649 | 69 |
31 Dec 21 | 12,142 | 2,355 | 2,995 | 71 |
30 Sep 21 | 11,959 | 2,531 | 2,899 | 60 |
30 Jun 21 | 11,816 | 2,551 | 2,865 | 54 |
31 Mar 21 | 9,980 | 1,831 | 2,746 | 54 |
31 Dec 20 | 9,132 | 1,372 | 2,590 | 64 |
30 Sep 20 | 8,613 | 1,207 | 2,545 | 67 |
30 Jun 20 | 7,962 | 1,034 | 1,890 | 73 |
31 Mar 20 | 8,564 | 1,273 | 2,567 | 69 |
31 Dec 19 | 8,513 | 1,463 | 2,601 | 60 |
30 Sep 19 | 8,189 | 1,355 | 2,563 | 60 |
30 Jun 19 | 7,887 | 1,230 | 2,544 | 57 |
31 Mar 19 | 7,612 | 1,201 | 2,486 | 56 |
31 Mar 18 | 6,472 | 1,042 | 2,008 | 57 |
31 Mar 17 | 5,447 | 1,017 | 1,658 | 25 |
31 Mar 16 | 4,755 | 768 | 1,388 | 31 |
31 Mar 15 | 4,555 | 610 | 1,181 | 37 |
31 Mar 14 | 3,883 | 566 | 932 | 35 |
Ingresos de calidad: METROPOLIS tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(10.8%) de METROPOLIS son inferiores a los del año pasado (12.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de METROPOLIS han crecido un 3.6% al año en los últimos 5 años.
Acelerando crecimiento: METROPOLIS ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: METROPOLIS tuvo un crecimiento negativo de los beneficios (-16.6%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (29.5%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de METROPOLIS (12%) se considera baja.